Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
GHK-Cu (Copper Peptide) is a naturally occurring copper-binding tripeptide studied for its role in dermal remodeling, collagen synthesis signaling, and antioxidant enzyme regulation. BPC-157 is a synthetic pentadecapeptide fragment studied for its role in angiogenesis and gastrointestinal mucosal repair. Both are frequently discussed together in tissue-repair research because they are structurally unrelated but mechanistically complementary, a common source of provider questions about whether the two overlap or should be considered separately.
| Structure | Tripeptide, copper-binding | Synthetic 15-amino-acid fragment |
| Primary research focus | Dermal/connective tissue remodeling, collagen signaling | Angiogenesis, gastric mucosal and soft-tissue repair |
| Proposed mechanism | Copper-dependent modulation of matrix metalloproteinases and their inhibitors | VEGF receptor-2 up-regulation, nitric oxide pathway modulation |
| Research register | Dermatology/connective-tissue literature | Gastroenterology/orthopedic-injury literature |
| Delivery formats studied | Injectable and topical (research contexts differ significantly by route) | Injectable, oral, and nasal formulations studied |
GHK-Cu’s research interest centers on its copper-dependent signaling role: it has been studied for modulating matrix metalloproteinase activity and their tissue inhibitors (TIMPs), a pathway relevant to skin and connective-tissue remodeling. BPC-157’s research interest centers on angiogenic and cytoprotective signaling, historically studied in gastric-mucosal injury models and more recently in tendon, ligament, and muscle repair models. The two compounds are not interchangeable substitutes. They are studied for different tissue compartments and through largely non-overlapping proposed pathways.
Because these are structurally and mechanistically distinct compounds, a provider evaluating either or both should request compound-specific documentation rather than a single generic quality statement:
Full pricing, ordering, and batch-specific Certificates of Analysis for both compounds are available exclusively to verified providers.
GHK-Cu is a copper-binding tripeptide studied primarily in dermal and connective-tissue research, while BPC-157 is a synthetic pentadecapeptide studied in angiogenesis, gastrointestinal, and soft-tissue research models.
Research involving GHK-Cu has examined dermal remodeling, collagen-related signaling, extracellular matrix regulation, and antioxidant enzyme activity. Its research profile is distinct from that of BPC-157.
BPC-157 has been investigated in preclinical models involving angiogenic signaling, gastrointestinal mucosal protection, and soft-tissue repair. Much of the evidence remains experimental.
GHK-Cu research focuses on copper-dependent signaling and pathways involving matrix metalloproteinases and tissue inhibitors of metalloproteinases (TIMPs). BPC-157 research has examined angiogenic and cytoprotective pathways, including VEGF-related and nitric oxide signaling.
No. GHK-Cu is a naturally occurring copper-binding tripeptide, while BPC-157 is a synthetic 15-amino-acid peptide fragment. Their structures and proposed biological mechanisms are different.
They can be evaluated together in experimental research when the study is designed to investigate their distinct mechanisms. However, evidence for one compound should not automatically be interpreted as evidence for the combination.
No. The compounds have different structures, proposed mechanisms, and research applications. Selection for a laboratory study should depend on the specific research question and experimental model.
These products are intended for laboratory research use only. They are not drugs, foods, cosmetics, or medical treatments and must not be used for any form of human or animal administration. All information provided is for educational and scientific reference only and the products should be handled exclusively by licensed, qualified professionals. Misbranding, misuse, or mislabeling of these products as therapeutic or consumable substances is strictly prohibited by law.
CellGenic ships exclusively to Mexico, Argentina, Colombia, and Perú under local license. Verified-provider-only platform from CellGenic.